Bridging agronomy and pharmacology the antidiabetic promise of Oldenlandia

Read full text Summarise with VIRAT
Authors: Nor Isnaeni Dwi Arista, Yochidamai Akhsanitaqwim
Cited by: 0
References: 47

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: The growing global burden of diabetes and the limitations of current treatments require sustainable alternatives. This study aims to evaluate the potential of the weedy genus Oldenlandia as a novel, sustainable resource for diabetes management by synthesizing evidence from agronomy, phytochemistry, and pharmacology. Methods: A systematic literature review was conducted using major scientific databases. A multidisciplinary search strategy was employed, and the collected data were integrated using narrative synthesis. Findings: The analysis shows that Oldenlandia species are resilient plants requiring low agricultural inputs. They are rich in bioactive compounds like iridoids and flavonoids, and preclinical studies confirm significant antidiabetic effects, including lowered blood glucose and reduced inflammation via mechanisms such as AMPK-NF-κB pathway modulation. Conclusion: Oldenlandia presents a promising and sustainable candidate for developing new antidiabetic therapies, bridging traditional use with scientific validation. Novelty/Originality: This review offers a novel, integrated perspective that simultaneously evaluates the agronomic feasibility and pharmacological potential of a weed for diabetes treatment, a unique approach not commonly found in existing literature.

Fields of Study & Subjects

Natural Antidiabetic Agents Studies Medicinal Plant Research Phytochemistry and Biological Activities

Publication details

Journal / source
Bioculture Journal
Volume
3
Issue
2
Pages
105–125
Publication date
30 January 2026
Language
EN